Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
about
Drug treatment of pulmonary hypertension in childrenInhaled nitric oxide in the neonatal period.Pulmonary hypertension in infants with bronchopulmonary dysplasiaTyrosine nitration: localisation, quantification, consequences for protein function and signal transduction.Monitoring cardiovascular function in infants with chronic lung disease of prematurity.Inhaled nitric oxide prevents 3-nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.Opposing regulation of human alveolar type II cell differentiation by nitric oxide and hyperoxia.Safety and efficacy of nitric oxide in chronic lung diseaseCurrent pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia.Prospective analysis of pulmonary hypertension in extremely low birth weight infants.Rescue Treatment with L-Citrulline Inhibits Hypoxia-Induced Pulmonary Hypertension in Newborn Pigs.Nitrative stress, oxidative stress and plasma endothelin levels after inhalation of particulate matter and ozone.Lung injury and bronchopulmonary dysplasia in newborn infants.Scoring method for early prediction of neonatal chronic lung disease using modified respiratory parametersThe pulmonary circulation in neonatal respiratory failure.Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension.Progress in understanding the pathogenesis of BPD using the baboon and sheep models.Inhaled nitric oxide for the prevention of bronchopulmonary dysplasia.Guidelines for Rational and Cost-Effective Use of iNO Therapy in Term and Preterm InfantsInhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome.Role of iNO in the modulation of pulmonary vascular resistance.Current strategies for treating infants with severe bronchopulmonary dysplasia.Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia.Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newbornTetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs.Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia.Oxygen tension and inhaled nitric oxide modulate pulmonary levels of S-nitrosocysteine and 3-nitrotyrosine in rats.Early inhaled nitric oxide improves oxidative balance in very preterm infants.Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia.Differential effects of inhaled nitric oxide and hyperoxia on pulmonary dysfunction in newborn guinea pigs.Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.Acute effects of inhaled nitric oxide on pulmonary and cardiac function in preterm infants with evolving bronchopulmonary dysplasia.Endostatin and vascular endothelial cell growth factor (VEGF) in piglet lungs: effect of inhaled nitric oxide and hyperoxia.
P2860
Q26996078-F5C5E71A-3763-4A78-B7D5-57457EFC0D58Q34074965-60923892-FBF7-4112-83FB-D3DAE7421572Q34363041-12A9B1C7-56EC-4F31-AA33-932E0A1A82FDQ34430029-C9F19B63-F8FB-46F6-A500-1F876338BB1AQ34714576-E63BB84E-C247-4D5F-A382-F4866A465E98Q34726576-9338F504-F141-43A3-88C1-14A1DFAB55EAQ34732153-F5F9B2EA-FB65-4106-81C6-72572F03B803Q35291458-A26B1E33-B27C-4AA6-9174-1F2A52A6E3CAQ35675944-462B109E-1712-4B12-9AA0-9F3871736490Q35787835-5B50C81B-C9A7-4749-9DCD-5EB0FDA9A0ADQ36049218-99651FB8-38E5-4EF9-A528-2B61393E7109Q36070666-7A32106A-A869-4EC7-805E-F082C0743FFBQ36108257-4647E574-0B43-41D1-8186-14A3C846578FQ36161938-25145DB8-C0F9-485E-9786-D7E9C748DDE6Q36687766-EBC1CE54-3AA1-4AD9-AB71-25C15F094384Q36747093-8FF0BA07-A2E4-4087-8FF7-996B49E77637Q36877324-5B98AEA9-6355-4780-9648-E56A3A24C964Q36895849-5714E392-CD60-42EC-B593-929221E18DAAQ37094554-4C6AFCA4-972C-49BB-AB6F-BEA7E7D0A7AAQ37275095-089A1BDF-B58E-4A7D-A2CD-DD243DBDDB8CQ37341687-A36025F3-BABD-4551-8457-B64CAE326400Q38046912-C2CB6B84-37FB-4440-B7CB-11956B90BCCEQ38271628-7AB4DE69-74AD-4746-953C-E87C20FC77DDQ41180077-CE662D93-BC95-45B6-B44C-A55555E297B3Q41630719-25E501C8-5672-4C7C-B263-8A0D3D8D2EBBQ43940289-E9D6EAFF-C0E9-4471-9DB7-5AAFA40E554BQ44969050-B1DE1A42-B63E-43D2-B056-D3184FA88D43Q45299611-BF3964B3-8693-4C5D-B692-E9F1B9D0ADD9Q45743135-623D8F15-C68A-45F1-9B4A-35050EDA2137Q46626342-2E32D152-9CC8-4306-9995-FC2D3CB61439Q47820131-14B70B09-70E6-4D6C-B47D-CF75CA83CAD5Q47908837-E725814F-F7F6-460F-ADE0-BE0911FD2090Q51685302-BA046650-39CD-4A60-936C-F8B9A1880391
P2860
Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
@en
type
label
Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
@en
prefLabel
Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
@en
P2093
P356
P1433
P1476
Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
@en
P2093
P304
P356
10.1542/PEDS.103.3.610
P407
P577
1999-03-01T00:00:00Z